Global Software as a Medical Device (SaMD) Market Growth (Status and Outlook) 2023-2029
SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.
LPI (LP Information)' newest research report, the “Software as a Medical Device (SaMD) Industry Forecast” looks at past sales and reviews total world Software as a Medical Device (SaMD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Software as a Medical Device (SaMD) sales for 2023 through 2029. With Software as a Medical Device (SaMD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Software as a Medical Device (SaMD) industry.
This Insight Report provides a comprehensive analysis of the global Software as a Medical Device (SaMD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Software as a Medical Device (SaMD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Software as a Medical Device (SaMD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Software as a Medical Device (SaMD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Software as a Medical Device (SaMD).
The global Software as a Medical Device (SaMD) market size is projected to grow from US$ 1025.2 million in 2022 to US$ 10720 million in 2029; it is expected to grow at a CAGR of 39.8% from 2023 to 2029.
According to types, the most proportion of the Global Software as a Medical Device market share is Cloud-based, taking about 67.34% share of global market in 2020. The most proportion of the Global Software as a Medical Device market share is used for Monitoring and Alerting and the proportion is about 41.55% in 2020.
This report presents a comprehensive overview, market shares, and growth opportunities of Software as a Medical Device (SaMD) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cloud-based
On Premise
Segmentation by application
Screening and Diagnosis
Monitoring and Alerting
Chronic Disease Management
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
MindMaze
Medtronic
Viz.AI.
Siemens Healthcare
iSchemaView
Arterys
Adherium
Digital Diagnostics
Allscripts
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook